Cannabics Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
If you work at Cannabics Pharmaceuticals Inc and you wish to licence your ESG aseessment, please contact us. This page displays a free Environmental, Social and Governance analysis for Cannabics Pharmaceuticals Inc. The dashboard includes a Q&A section on Cannabics Pharmaceuticals Inc.
Cannabics Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 0.0, social score of 2.7 and governance score of 5.3.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1393 | Vaccinex Inc | 2.8 | Medium |
| 1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
| 1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
| 1437 | CanadaBis Capital Inc | 2.7 | Medium |
| 1437 | Black Diamond Therapeutics Inc | 2.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cannabics Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cannabics Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cannabics Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cannabics Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Cannabics Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cannabics Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cannabics Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.